New pill targets Hard-to-Treat cancers in early trial
Disease control
Recruiting now
This early-phase study tests a new drug, JMKX005425, in about 102 adults with advanced solid tumors that have high microsatellite instability or mismatch repair deficiency. The main goal is to check safety and find the right dose. Researchers will also look at how the drug moves …
Phase: PHASE1 • Sponsor: Jemincare • Aim: Disease control
Last updated May 15, 2026 11:57 UTC